CHICAGO -- A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely vision-impaired and blind patients, a randomized clinical trial showed. After ...

SEATTLE--(BUSINESS WIRE)--LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the topline results from the LIGHTSITE ...

While leaders are constantly striving for better strategy, sharper insights and stronger resilience, I think many underestimate a critical factor influencing their performance: Eyesight. Eye health ...

Technology provides access to vast information and makes daily life easier. Yet, too much reliance on technology potentially interferes with the acquisition and maintenance of critical thinking skills ...